SCHEMBL4264298

SCHEMBL4264298

C[C@@H]1OC(OC[C@H]2O[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@@H]1O

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AMY2A P04746 9/20 0.62
▸ AMY1A P0DUB6 3/20 0.57
▸ LGALS8 O00214 1/20 0.51
▸ LGALS3 P17931 1/20 0.51
▸ LGALS4 P56470 1/20 0.51
▸ ENGASE Q8NFI3 1/20 0.51
▸ GAA P10253 4/20 0.48
▸ MGAM O43451 2/20 0.48
▸ SI P14410 1/20 0.48
▸ CNR1 P21554 1/20 0.48
▸ PTGS1 P23219 1/20 0.48
▸ PDE4A P27815 1/20 0.48
▸ PDE3A Q14432 1/20 0.48
▸ MGAM2 Q2M2H8 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ GLA P06280 1/20 0.48
▸ CD209 Q9NNX6 1/20 0.48
▸ CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27235 1.00 AMY2A (0.62) AMY2AAMY1ALGALS8LGALS3LGALS4
SCHEMBL10702505 1.00 AMY2A (0.62) AMY2AAMY1ALGALS8LGALS3LGALS4
SCHEMBL20169497 0.92 AMY2A (0.55) AMY2AAMY1ALGALS8LGALS3LGALS4
SCHEMBL24495313 0.92 LGALS8 (0.56) AMY2AAMY1ALGALS8LGALS3LGALS4
SCHEMBL12648833 0.92 LGALS8 (0.56) AMY2AAMY1ALGALS8LGALS3LGALS4
SCHEMBL12595483 0.92 LGALS8 (0.56) AMY2AAMY1ALGALS8LGALS3LGALS4
SCHEMBL16510207 0.92 LGALS8 (0.56) AMY2AAMY1ALGALS8LGALS3LGALS4
SCHEMBL16506646 0.92 LGALS8 (0.56) AMY2AAMY1ALGALS8LGALS3LGALS4
SCHEMBL12595429 0.92 LGALS8 (0.56) AMY2AAMY1ALGALS8LGALS3LGALS4
SCHEMBL21243215 0.91 LGALS3 (0.60) AMY2ALGALS8LGALS3LGALS4ENGASE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047272-A1 Compositions with Modified Nucleases Targeted to Viral Nucleic Acids and Methods of Use for Prevention and Treatment of Viral Diseases NANONASE, INC. 2009-02-19 — — US claimed
EP-1734991-A2 COMPOSITIONS WITH MODIFIED NUCLEASES TARGETED TO VIRAL NUCLEIC ACIDS AND METHODS OF USE FOR PREVENTION AND TREATMENT OF VIRAL DISEASES Avirid, Inc. (US) 2006-12-27 — — EP claimed
WO-2005115444-A2 COMPOSITIONS WITH MODIFIED NUCLEASES TARGETED TO VIRAL NUCLEIC ACIDS AND METHODS OF USE FOR PREVENTION AND TREATMENT OF VIRAL DISEASES AVIRID, INC. (US) 2005-12-08 — — WO claimed
US-10335372-B2 Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases Appelbaum, Jacob G. (US) 2019-07-02 — — US disclosed
US-20170209376-A1 COMPOSITIONS WITH MODIFIED NUCLEASES TARGETED TO VIRAL NUCLEIC ACIDS AND METHODS OF USE FOR PREVENTION AND TREATMENT OF VIRAL DISEASES NANONASE, INC. 2017-07-27 — — US disclosed
US-9592277-B2 Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases AVIRID, INC. (US) 2017-03-14 — — US disclosed
US-20090047272-A1 Compositions with Modified Nucleases Targeted to Viral Nucleic Acids and Methods of Use for Prevention and Treatment of Viral Diseases NANONASE, INC. 2009-02-19 — — US disclosed
EP-1734991-A2 COMPOSITIONS WITH MODIFIED NUCLEASES TARGETED TO VIRAL NUCLEIC ACIDS AND METHODS OF USE FOR PREVENTION AND TREATMENT OF VIRAL DISEASES Avirid, Inc. (US) 2006-12-27 — — EP disclosed
WO-2005115444-A2 COMPOSITIONS WITH MODIFIED NUCLEASES TARGETED TO VIRAL NUCLEIC ACIDS AND METHODS OF USE FOR PREVENTION AND TREATMENT OF VIRAL DISEASES AVIRID, INC. (US) 2005-12-08 — — WO disclosed
US-4927753-A FUCOSE DEHYDROGENASE TAKARA SHUZO CO., LTD. (JP) 1990-05-22 — — US disclosed
Send feedback